Literature DB >> 27788985

Intrinsic colistin resistance.

Kai Zhou1, Vincent Cattoir2, Yonghong Xiao3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27788985     DOI： 10.1016/S1473-3099(16)30394-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

Authors:  Shio-Shin Jean; Min-Chi Lu; Zhi-Yuan Shi; Shu-Hui Tseng; Ting-Shu Wu; Po-Liang Lu; Pei-Lan Shao; Wen-Chien Ko; Fu-Der Wang; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2018-10-26       Impact factor: 4.003

2.  Lipid A-Ara4N as an alternate pathway for (colistin) resistance in Klebsiella pneumonia isolates in Pakistan.

Authors:  Kiran Iqbal Masood; Seema Umar; Zahra Hasan; Joveria Farooqi; Safina Abdul Razzak; Nazish Jabeen; Jason Rao; Sadia Shakoor; Rumina Hasan
Journal:  BMC Res Notes       Date:  2021-12-14

Review 3.  Antimicrobial Resistance in Agri-Food Chain and Companion Animals as a Re-emerging Menace in Post-COVID Epoch: Low-and Middle-Income Countries Perspective and Mitigation Strategies.

Authors:  Samiran Bandyopadhyay; Indranil Samanta
Journal:  Front Vet Sci       Date:  2020-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.